Bone‐Targeted Fluoropeptide Nanoparticle Inhibits NF‐κB Signaling to Treat Osteosarcoma and Tumor‐Induced Bone Destruction
Abstract Osteosarcoma is a malignant bone cancer usually characterized by symptoms of bone loss due to pathologically enhanced osteoclast activity. Activated osteoclasts enhance bone resorption and promote osteosarcoma cell progression by secreting various cytokines. Intercepting the detrimental int...
Saved in:
Main Authors: | Lin Li, Guangyu Rong, Xin Gao, Yiyun Cheng, Zhengwang Sun, Xiaopan Cai, Jianru Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202412014 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two decades of fluorine chemistry in Cergy
by: Pytkowicz, Julien, et al.
Published: (2024-12-01) -
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
by: Shaoyan Shi, et al.
Published: (2025-01-01) -
1.4 nm gold nanoparticle-antibody conjugates for in situ gold immunolabelling after transduction into living human cells
by: Groysbeck, Nadja, et al.
Published: (2023-10-01) -
Small cell osteosarcoma in gnathic bones in the maxilla: case report in a pediatric patient
by: Tayná Souza Gomes da Silva, et al.
Published: (2025-01-01) -
An analysis of extraskeletal osteosarcoma based on the literature
by: De-Hui Wang, et al.
Published: (2025-01-01)